Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 12 of 25

  1. The aim of this study was to (1) evaluate the ability of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters to predict suboptimal cytoreduction and (2) to create a ri...

    Authors: Gun Oh. Chong, Shin Young Jeong, Yoon Hee Lee, Hyun Jung Lee, Sang-Woo Lee, Hyung Soo Han, Dae Gy Hong and Yoon Soon Lee
    Citation: Journal of Ovarian Research 2019 12:12
  2. All-trans retinoic acid (ATRA) is currently being used to treat hematological malignancies, given the ability to inhibit cell proliferation. This effect seems to be related to epigenetic changes of the TERT (Telo...

    Authors: Lorena Losi, Angela Lauriola, Erica Tazzioli, Gaia Gozzi, Letizia Scurani, Domenico D’Arca and Jean Benhattar
    Citation: Journal of Ovarian Research 2019 12:62
  3. Bcl-2 plays a major role in the pathobiology and drug resistance of ovarian cancer, and inhibition of bcl-2 was useful ... inhibited cell growth and induced apoptosis in many cancer cells. In the present study,we...

    Authors: Haixia Wang, Zhifeng Zhang, Xiuping Wei and Ruizhen Dai
    Citation: Journal of Ovarian Research 2015 8:3
  4. To analyze the clinical characteristics and chemo-resistance related factors of patients with resistant and non-resistant endometriosis-associated ovarian cancer (ovarian clear cell carcinoma and endometrioid car...

    Authors: Tong Ren, Ting-Ting Sun, Shu Wang, Jian Sun, Yang Xiang, Keng Shen and Jing-He Lang
    Citation: Journal of Ovarian Research 2018 11:40
  5. Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is...

    Authors: Soo Young Jeong, Chel Hun Choi, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae and Yoo-Young Lee
    Citation: Journal of Ovarian Research 2019 13:1
  6. An early step of advanced ovarian cancer begins when floating cancerous cells as single ... profound effects on cellular behaviour and can facilitate cancer progression. Subsequently, this ECM may alter cellular ...

    Authors: Simon J. Hogg, John J. Evans, Peter H. Sykes and Kenny Chitcholtan
    Citation: Journal of Ovarian Research 2015 8:43
  7. Ovarian cancer remains the most fatal gynecologic malignancy worldwide ... or supplement existing tools is urgently needed. Cancer-testis antigens (CTAs) are exclusively expressed ... tissues but abundantly found...

    Authors: Kaipeng Xie, Chenyang Fu, Suli Wang, Hanzi Xu, Siyu Liu, Yang Shao, Zhen Gong, Xiaoli Wu, Bo Xu, Jing Han, Juan Xu, Pengfei Xu, Xuemei Jia and Jiangping Wu
    Citation: Journal of Ovarian Research 2019 12:1
  8. Despite years of research, the treatment options and mortality rate for ovarian cancer remain relatively stagnant. Resistance to chemotherapy and high heterogeneity in mutations contribute to ovarian cancer’s let...

    Authors: Katherine Redd Bowman, Ji Hoon Kim and Carol S. Lim
    Citation: Journal of Ovarian Research 2019 12:38
  9. Circular RNAs (circRNAs) are a class of long non-coding RNAs (lncRNAs) which have a circular and closed loop structure. They are ubiquitous, stable, conserved and diverse RNA molecules with a range of activities ...

    Authors: Zahra Shabaninejad, Asma Vafadar, Ahmad Movahedpour, Younes Ghasemi, Afshin Namdar, Hadis Fathizadeh, Mohammad Hossein Pourhanifeh, Amir Savardashtaki and Hamed Mirzaei
    Citation: Journal of Ovarian Research 2019 12:84
  10. Mutation in the tumor suppressor gene TP53...is an early event in the development of high-grade serous (HGS) ovarian cancer and is identified in more than 96 % of HGS cancer patients. APR-246 (PRIMA-1MET...) is t...

    Authors: Åsa Fransson, Daria Glaessgen, Jessica Alfredsson, Klas G. Wiman, Svetlana Bajalica-Lagercrantz and Nina Mohell
    Citation: Journal of Ovarian Research 2016 9:27
  11. The most common gynecologic cancers detected in women in Turkey are uterine cancer, ovarian cancer, and cervical cancer. These data reported that a mean of 3800 individuals were diagnosed with uterine cancer, 279...

    Authors: Arash Adamnejad Ghafour, Demet Akdeniz Odemis, Seref Bugra Tuncer, Busra Kurt, Mukaddes Avsar Saral, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Betul Celik, Pinar Saip and Hulya Yazici
    Citation: Journal of Ovarian Research 2021 14:131
  12. The p38MAPK family of Mitogen Activated Protein Kinases are a group of signalling molecules involved in cell growth, survival, proliferation and differentiation. The widely studied p38α isoform is ubiquitously ex...

    Authors: Periklis Katopodis, Rachel Kerslake, Athanasios Zikopoulos, Nefeli Beri and Vladimir Anikin
    Citation: Journal of Ovarian Research 2021 14:84
  13. There are no effective methods of diagnosis of early-stage ovarian cancer. Conservative care over patients at high risk of ovarian and breast cancers is ineffective. Prophylactic surgery is considered the...

    Authors: Janusz Menkiszak, Anita Chudecka-Głaz, Jacek Gronwald, Aneta Cymbaluk-Płoska, Aleksander Celewicz, Maria Świniarska, Małgorzata Wężowska, Ryszard Bedner, Dorota Zielińska, Paulina Tarnowska, Jerzy Jakubowicz and Zbigniew Kojs
    Citation: Journal of Ovarian Research 2016 9:11
  14. Ovarian cancer stem cells (OCSCs) contribute to the poor prognosis of ovarian cancer. Involvement of the androgen receptor (AR) ... this interaction induced stem-like properties in ovarian cancer cells.

    Authors: Kaijian Ling, Lupin Jiang, Shi Liang, Joseph Kwong, Leiyan Yang, Yudi Li, PingYin, Qingchun Deng and Zhiqing Liang
    Citation: Journal of Ovarian Research 2018 11:36

    The Correction to this article has been published in Journal of Ovarian Research 2019 12:11

  15. One of side effects of chemotherapy and radiotherapy is the induction of several factors in various tissues and organs that create a pro-metastatic microenvironment for cancer cells that survive initial treatment...

    Authors: Pranesh M Gunjal, Gabriela Schneider, Ahmed Abdelbaset Ismail, Sham S Kakar, Magda Kucia and Mariusz Z Ratajczak
    Citation: Journal of Ovarian Research 2015 8:20
  16. Ovarian cancer is a leading cause of the death ... , the molecular mechanism of hypoxia-regulated ovarian cancer cells remains unclear. Thus, this study...

    Authors: Ke Zhang, Xiangjun Kong, Guangde Feng, Wei Xiang, Long Chen, Fang Yang, Chunyu Cao, Yifei Ding, Hang Chen, Mingxing Chu, Pingqing Wang and Baoyun Zhang
    Citation: Journal of Ovarian Research 2018 11:16
  17. Ovarian cancer is the leading cause of gynecological cancer-related mortality. The novel oncogene S100A10 has been reported to be involved in cancer cell proliferation, invasion and metastasis. The role of S100A1...

    Authors: Lingzhi Wang, Wei Yan, Xukun Li, Zhihua Liu, Tian Tian, Tanxiu Chen, Liang Zou and Zhumei Cui
    Citation: Journal of Ovarian Research 2019 12:113
  18. Despite advances in surgical aggressiveness and conventional chemotherapy, ovarian cancer remains the most lethal cause of gynecologic cancer mortality; consequently there is a need for ... innovative treatment p...

    Authors: Eric D. Thomas, Selene Meza-Perez, Kerri S Bevis, Troy D. Randall, G. Yancey Gillespie, Catherine Langford and Ronald D. Alvarez
    Citation: Journal of Ovarian Research 2016 9:70
  19. To investigate whether miR-203a-3p can regulate the biological behaviors of ovarian cancer cells by targeting ATM to affect the Akt/GSK-3β/Snail signaling pathway.

    Authors: Hong-Yun Liu, Yu-Ying Zhang, Bao-Lian Zhu, Fu-Zhong Feng, Hai-Tang Zhang, Hua Yan and Bin Zhou
    Citation: Journal of Ovarian Research 2019 12:60
  20. Breast cancer associated (BRCA) genes are critical for DNA repair. Mutations in BRCA1 and BRCA2 (BRCAm) result in loss of these repair mechanisms and potential carcinogenesis. Germline BRCAm are common in ovarian...

    Authors: Sudhir K. Unni, Marisa B. Schauerhamer, Rishi Deka, Jerzy E. Tyczynski, Ancilla W. Fernandes, Vanessa Stevens, Diana I. Brixner and David D. Stenehjem
    Citation: Journal of Ovarian Research 2016 9:18
  21. Ovarian cancer is the leading lethal, gynecological malignancy in ... , the continued morbidity and mortality of ovarian cancer reflects a poor understanding of invasive mechanisms. Recent studies reveal that ova...

    Authors: Jun Wei, Lahong Zhang, Jennifer Li, Shuguang Zhu, Minghui Tai, Clifford W. Mason, Julia A. Chapman, Evelyn A. Reynolds, Carl P Weiner and Helen H Zhou
    Citation: Journal of Ovarian Research 2017 10:33
  22. Epithelial ovarian cancer is the most lethal gynecologic malignancy. In...BRCA1 and BRCA2..., which encode proteins essential for the repair of double-strand DNA breaks through homologous recombination, lead to i...

    Authors: Angiolo Gadducci, Valentina Guarneri, Fedro Alessandro Peccatori, Graziana Ronzino, Giuseppa Scandurra, Claudio Zamagni, Paolo Zola and Vanda Salutari
    Citation: Journal of Ovarian Research 2019 12:9
  23. Ovarian cancer has the highest ratio of mortality among ... of the most common treatment options for ovarian cancer. However, tumor relapse in patients with...

    Authors: Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad and Mohammad Reza Abbaszadegan
    Citation: Journal of Ovarian Research 2019 12:120
  24. Ovarian cancer is the leading cause of gynecologic cancer death in the United States despite effective first-line systemic chemotherapy. Cancer stem cells (CSCs) retain the ability ... to validate Thy-1 (CD90) as...

    Authors: Elizabeth V. Connor, Caner Saygin, Chad Braley, Andrew C. Wiechert, Sheelarani Karunanithi, Katie Crean-Tate, Fadi W. Abdul-Karim, Chad M. Michener, Peter G. Rose, Justin D. Lathia and Ofer Reizes
    Citation: Journal of Ovarian Research 2019 12:112
  25. Ovarian cancer is the main cause of death among all reproductive cancers in females. In 2018, ovarian cancer was the seventh most common cancer of women entire the world. A wide ... to therapies in the different ...

    Authors: Rana Shafabakhsh and Zatollah Asemi
    Citation: Journal of Ovarian Research 2019 12:55
  26. To demonstrate the use of surface-enhanced Raman spectroscopy (SERS) to determine sialic acid (SA) levels in saliva using silver nanoparticles as substrates, in adnexal mass patients scheduled for surgical interv...

    Authors: José de Jesús Zermeño-Nava, Marco Ulises Martínez-Martínez, Ana Laura Rámirez-de-Ávila, Aida Catalina Hernández-Arteaga, Ma. Guadalupe García-Valdivieso, Alondra Hernández-Cedillo, Miguel José-Yacamán and Hugo Ricardo Navarro-Contreras
    Citation: Journal of Ovarian Research 2018 11:61
  27. Extracellular vesicles (EVs) are considered as a new class of resources for potential biomarkers. We analyzed expression of specific mRNA and miRNA in EVs derived from ovarian cancer ascites and the ideal control...

    Authors: Cindy M. Yamamoto, Melanie L. Oakes, Taku Murakami, Michael G. Muto, Ross S. Berkowitz and Shu-Wing Ng
    Citation: Journal of Ovarian Research 2018 11:20
  28. Ovarian cancer is one of the most common causes ... . Possible risk factors are including hereditary ovarian cancer, obesity, diabetes mellitus, alcohol consumption, ... angiogenesis are involved in this progress...

    Authors: Hadis Zare, Rana Shafabakhsh, Russel J. Reiter and Zatollah Asemi
    Citation: Journal of Ovarian Research 2019 12:26
  29. Discoidin Domain Receptor 1 (DDR1) belongs to the family of collagen receptor tyrosine kinases that confers the progression of various cancers. Aberrant expression of DDR1 was detected in several human cancers in...

    Authors: Yuao Deng, Fang Zhao, Liu Hui, Xiuyun Li, Danyu Zhang, Wang Lin, Zhiqiang Chen and Yingxia Ning
    Citation: Journal of Ovarian Research 2017 10:50
  30. The standard front-line therapy for epithelial ovarian cancer (EOC) is combination of debulking surgery ... extensive efforts to find new therapeutic options, cancer cells invariably develop drug resistance and d...

    Authors: Gloria Mittica, Sonia Capellero, Sofia Genta, Celeste Cagnazzo, Massimo Aglietta, Dario Sangiolo and Giorgio Valabrega
    Citation: Journal of Ovarian Research 2016 9:30
  31. Epithelial ovarian cancer is one of the most severe public ... that play an essential role in epithelial ovarian cancer initiation and progression is of vital importance.

    Authors: Wenyu Li, Zheran Liu, Bowen Liang, Siyang Chen, Xinping Zhang, Xiaoqin Tong, Weiming Lou, Lulu Le, Xiaoli Tang and Fen Fu
    Citation: Journal of Ovarian Research 2018 11:94
  32. The frequency of BRCA1 and BRCA2 mutations in ovarian cancer patients varies depending on histological subtype and ... defined ovarian, fallopian tube and primary peritoneal cancer cases that were ascertained at ...

    Authors: Moria H Belanger, Lena Dolman, Suzanna L Arcand, Zhen Shen, George Chong, Anne-Marie Mes-Masson, Diane Provencher and Patricia N Tonin
    Citation: Journal of Ovarian Research 2015 8:1
  33. Ovarian carcinoma is a lethal gynecological malignancy. Women with ovarian cancer (OC) are highly recurrent and typically ... studies indicated that TET3 is overexpressed in ovarian cancer tissues. However, the c...

    Authors: Tiefeng Cao, Wenwei Pan, Xiaoli Sun and Huimin Shen
    Citation: Journal of Ovarian Research 2019 12:101
  34. Ovarian cancer is the second most common gynecologic cancer with high mortality rate and generally diagnosed ... expression of miRNAs were found in numerous human cancer, including ovarian cancer. Investigating t...

    Authors: Seref Bugra Tuncer, Ozge Sukruoglu Erdogan, Seda Kilic Erciyas, Mukaddes Avsar Saral, Betul Celik, Demet Akdeniz Odemis, Gozde Kuru Turkcan and Hulya Yazici
    Citation: Journal of Ovarian Research 2020 13:99
  35. Multiple targeted gene sequencing is seldom performed in both germline and somatic testing for ovarian cancer. This study is to evaluate the specific ... mutations, in Chinese patients with epithelial ovarian cancer

    Authors: Wenhui Li, Di Shao, Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong, Fengming Guo, Zhe Wang and Mingzhi Ye
    Citation: Journal of Ovarian Research 2019 12:80

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.